These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5452049)

  • 21. [Current aspects of the surgical treatment of portal hypertension: mesenterico-caval anastomosis with prosthetic interposition].
    Peracchia A; Roncoroni L
    Ateneo Parmense Acta Biomed; 1973 Sep; 44(5):267-90. PubMed ID: 4276931
    [No Abstract]   [Full Text] [Related]  

  • 22. Elective splenorenal anastomosis.
    Riddell AG; Bloor K; Hobbs KE; Jacquet N
    Br Med J; 1972 Mar; 1(5802):731-2. PubMed ID: 4536911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portarenal shunt for hepatic cirrhosis and portal hypertension.
    Simeone FA; Hopkins RW
    Surgery; 1967 Jan; 61(1):153-68. PubMed ID: 5297341
    [No Abstract]   [Full Text] [Related]  

  • 24. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival from acute hepatorenal syndrome following splenorenal shunt.
    Fischer JE; Foster GS
    Ann Surg; 1976 Jul; 184(1):22-5. PubMed ID: 938113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portal hypertension as I see it.
    Turcotte JG
    Major Probl Clin Surg; 1974; 14(0):78-120. PubMed ID: 4604924
    [No Abstract]   [Full Text] [Related]  

  • 27. The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.
    Bayraktar Y; Balkanci F; Ozenc A; Arslan S; Koseoglu T; Ozdemir A; Uzunalimoglu B; Telatar H; Gurakar A; Van Thiel DH
    Am J Gastroenterol; 1995 Nov; 90(11):2015-9. PubMed ID: 7485013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To what extent is portal hypertension surgery affected by the progress made in splanchnic physiopathology and hepatic biology?
    Staudacher V; Bevilacqua G
    Int Surg; 1972 Jun; 57(6):488-90. PubMed ID: 5038826
    [No Abstract]   [Full Text] [Related]  

  • 29. [Distal splenorenal anastomosis in the treatment of portal hypertension in the cirrhotic patient (author's transl)].
    Jacquet N
    Acta Chir Belg; 1974 Sep; 73(5):539-53. PubMed ID: 4440368
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of modified splenocaval shunt plus devascularization on esophagogastric variceal bleeding: a comparative study of this treatment and devascularization only in cirrhotic portal hypertension.
    Du L; Wu W; Zhang Y; Sun Z; Hu H; Liu X; Liu Q
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):657-65. PubMed ID: 20703844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of esophageal varices in the patient with cirrhosis.
    Warren WD; Salam AA
    Adv Surg; 1972; 6():141-73. PubMed ID: 4570664
    [No Abstract]   [Full Text] [Related]  

  • 33. Causes of death among cirrhotic patients following portal decompression.
    Palmer ED
    JAMA; 1971 Mar; 215(10):1646-8. PubMed ID: 5313140
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the methods of veno-venous anastomosis in portal hypertension].
    Ratner GL; Mazokha VA
    Vestn Khir Im I I Grek; 1974 May; 112(5):22-6. PubMed ID: 4836980
    [No Abstract]   [Full Text] [Related]  

  • 35. The comparative survivals of alcoholics versus nonalcoholics after distal splenorenal shunt.
    Zeppa R; Hensley GT; Levi JU; Bergstresser PR; Hutson DG; Livingstone AS; Schiff ER; Fink P
    Ann Surg; 1978 May; 187(5):510-4. PubMed ID: 646490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
    Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z
    Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New trends in the surgical treatment of portal hypertension].
    Raia S; da Silva LC
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(1):35-8. PubMed ID: 5553902
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent progress in surgery of portal hypertension].
    Gasparini Filho S
    Hospital (Rio J); 1966 Nov; 70(5):1243-9. PubMed ID: 5301942
    [No Abstract]   [Full Text] [Related]  

  • 39. [Venous anastomosis in portal hypertension in children].
    Kamiński W; Gizycka I; Wysocka K
    Pol Tyg Lek; 1971 Aug; 26(35):1359-61. PubMed ID: 5098499
    [No Abstract]   [Full Text] [Related]  

  • 40. Inferior mesenteric venous left renal vein shunting for decompression of excessive portal hypertension in adult living related liver transplantation.
    Sato Y; Yamamoto S; Takeishi T; Kato T; Nakatsuka H; Kobayashi T; Oya H; Watanabe T; Kokai H; Hatakeyama K
    Transplant Proc; 2004 Oct; 36(8):2234-6. PubMed ID: 15561203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.